General Prognostics (GPx)

GPx is a digital therapeutics company pioneering Bloodless Blood Tests by leveraging AI to calibrate collected digital biomarkers with vital blood biomarkers, delivering clinically actionable information and revolutionizing chronic disease management on a timely and cost-effective basis that will optimize guideline directed medical therapy (GDMT) and reduce readmission.

HLTH does not sell or provide any personal data (including email, phone, address) to any third parties and we never will. Any communication that pretends to be HLTH or any third parties selling purported lists, discounted rooms, or any product/services are NOT AFFILIATED with HLTH and are to be considered FRAUD.

Upcoming Event Dates

2024 | ViVE: Feb 25-28; HLTH Europe: Jun 17-20; HLTH US: Oct 20-23

2025 | ViVE: Feb 16-19; HLTH US: Oct 19-22

2026 | HLTH US: Nov 15-18

2027 | HLTH US: Oct 17-20

© 2024 HLTH, INC. All Rights Reserved